We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2 trial. The results of the study were presented at AASLD The Liver Meeting on 4th-8th November.
Check the results in the following document.
![](http://comac-medical.com/wp-content/uploads/2022/08/pdf-icon-80x80.png)